NIH-funded research NIH-funded research

Promoting Chronic Wound Healing with Advanced Hydrogels

Official title: Combining soluble and bound factors in microstructured hydrogels to promote chronic wound angiogenesis and healing

Funded at University of New Hampshire · NIH-11329246 · Data updated 2026-11-12

A patient-friendly approach uses specially designed hydrogels that release and present growth-promoting signals to boost blood vessel growth and healing in chronic wounds.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of New Hampshire
NIH-funded
Lab location1 site (Durham, United States)
Project startJuly 1, 2024
Project endMay 31, 2029
Funding year2026
Award (this year)$378,929
NIH project number5R35GM155450-03
Project IDNIH-11329246 on NIH RePORTER

Who could benefit from this research

Could help

People with chronic wounds who could benefit from enhanced wound healing and new biomaterial therapies.

Less likely to help

Patients with wounds that heal naturally or those unable to participate in biomaterials research may not experience direct benefits.

What this research studies

This project aims to design biomaterials that combine soluble factors with bound signals to guide how blood vessels form in chronic wounds. By tuning how these signals are displayed in a three-dimensional hydrogel, researchers hope to control the strength and duration of healing cues. The work involves advanced chemistry and fabrication techniques to create a new system that mimics the wound environment and supports proper tissue repair. If successful, this platform could lead to better wound closure and reduced scarring for patients with long-standing wounds.

Why it matters

Potential benefit: If the approach succeeds, patients with chronic wounds could experience faster healing and fewer complications due to improved blood vessel formation.

How similar studies have gone: Previous biomaterials research shows promise in guiding tissue healing, with this project aiming to advance integration of soluble and bound signals for improved outcomes.

Where this research is happening

  • University of New Hampshire
    Durham, United States
    Active

Researchers

  • Principal investigator: Li, Linqing — University of New Hampshire
  • Study coordinator: Li, Linqing

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.